DataMeds AI, Inc.
Wholesale drugs, proprietaries & druggists’ sundries10 peers
- Last sale
- Nov 12, 2026 · -7.85%
- Market cap
- $4.14M
- 4.73M shares
- Filings
- 186
Q3 2026+28.7% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
—
—
—Q3 2026N/M FY25 yoy
Q3 2026−95.9% FY25 yoy
- $4.14M
- —
- 0.5×
- —
- —
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $23,337,860 | reported | |
| FY 2024 | 2024-12-31 | $18,128,831 | reported |
Segments
Products
LineFY2025ShareChange
Product$21.87M94%+23.8%
Pharmacy Retail Sales$865.70K3.7%+145.7%
Third Party Logistics Services$603.42K2.6%+463.9%
Total$23.34M
Wholesale drugs, proprietaries & druggists’ sundries
DataMeds AI, Inc. is the 7th largest of the 11 covered companies the SEC files under this code, by revenue. SIC 5122
CompanyRevenueGrowthNet marginMarket cap
MCKMcKesson Corp$403.4B12.4%1.2%$124.3BCORCencora, Inc.$321.3B9.3%0.5%$66.7BCAHCardinal Health Inc$254.2B14.2%0.7%$64.3BHLFHerbalife Ltd.$5.0B0.9%4.5%$1.6BNUSNU Skin Enterprises, Inc.$1.5B14.3%10.8%$195.7MCOSMCosmos Health Inc.$65.3M19.9%29.3%$20.8M
MEDSDataMeds AI, Inc. (this company)$23.3M28.7%433.9%$4.1M
STEKStemtech Corp$2.9M43.1%140.7%$1.6MESYNEnerSyn Global Inc.$866.9K30.8%303.4%$46.4MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
DataMeds AI, Inc. · CIK 2030763 · Engraved from SEC EDGAR